References
- 1. Gu S, Fan Z, Wang L, Tao X, Zhang Y, Mu G. Cor-neal Collagen Crosslinking with Hypoosmolar Riboflavin Solution in Keratoconic Corneas. Biomed Res Int. 2014;2014:754182. DOI: 10.1155/2014/75418210.1155/2014/754182415041525197657
- 2. de Bonis P, Laborante A, Pizzicoli C, Stallone R, Barbano R, Longo C et al. Mutational screening of VSX1, SPARC,SOD1, LOX, and TIMP3 in keratoconus. Mol Vis. 2011; 17: 2482-94.
- 3. Gordon-Shaag A, Millodot M, Shneor Liu Y. The genetic and environmental factors for keratoconus. Biomed Res Int. 2015;2015:795738. DOI: 10.1155/2015/79573810.1155/2015/795738444990026075261
- 4. Mas Tur V, MacGregor C, Jayaswal R, O”Brart D, Maycock N. A review of keratoconus:Diagnosis, pathophysiology, and genetics. Surv Opthalmol.2017;62(6):770-83. DOI: 10.1016/j.survophthal.2017.06.00910.1016/j.survophthal.2017.06.00928688894
- 5. Paliwal P, Singh A, Tandon R, Titiyal JS, Sharma A. A novel VSX 1 mutation identified in an individual with keratoconus in India. Mol Vis. 2009;15:2475-79.
- 6. Acera A, Vecino E, Agirretxe IR, Aloria K, Arizmendi JM, Morales C, Duran JA. Changes in tear protein profile in keratoconus disease. Eye. 2011; 25:1225-33. DOI: 10.1038/eye.2011.10510.1038/eye.2011.105317825021701529
- 7. Wilson SE, He YG, Weng J, Li Q, Mc Dowall AW, Vital M, Chwang Epithelial injury induces keratocyte apoptosis:hypothesized role for the interleukin-1 system in the modulation of corneal tissue organisation and wound healing. Exp Eye Res. 1996;62:325-27. DOI: 10.1006/exer.1996.003810.1006/exer.1996.00388795451
- 8. Lema I, Sobrino T, Duran JA, Brea D, Feijoo-Diez E. Subclinical keratoconus and inflammatory molecules from tears.Br J Ophthal. 2009;93(6):820-24. DOI: 10.1136/bjo.2008.14425310.1136/bjo.2008.14425319304583
- 9. Nishtala K, Pahuja N, Shetty R, MMA Nuijts R, Ghosh A. Tear biomarkers for keratoconus. Eye Vis. 2016;3(19):1-7 DOI: 10.1186/s40662-016-0051-910.1186/s40662-016-0051-9497311527493978
- 10. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174(5):1209-20. DOI: 10.1084/jem.174.5.120910.1084/jem.174.5.120921190011940799
- 11. Balasubramanian SA, Pye DC, Wilcoxx MDP. Levels of lactoferrin, secretory IgA and serum albumin in the tear of people with keratoconus. Exp Eye Res. 2011;96:132-37. DOI: 10.1016/j.exer.2011.12.01010.1016/j.exer.2011.12.01022197752
- 12. Mazzotta C, Balestrazzi A, Traversi C, Baiocchi S, Caporossi T, Tommasi C et al. Treatment of progressive keratoconus by riboflavin-UVA-induced crosslinking of corneal colagen:: ultrastructural analysis by Heidelberg Retinal Tomograph II in vivo confocal microscopy in humans. Cornea. 2007;26(4):390-97. DOI: 10.1097/ICO.0b013e318030df5a10.1097/ICO.0b013e318030df5a17457184
- 13. Flanagan JL, Willcox MDP. Role of lactoferrin in the tear film. Biochimie. 2009;91(1):35-43. DOI: 10.1016/j.biochi.2008.07.00710.1016/j.biochi.2008.07.00718718499
- 14. Lema I, Brea D, Rodriguez-Gonzales R, Diez-Feijoo E, Sobrino T. Proteomic analysis of the tear film in patients with keratoconus. Mol Vis. 2010;16:2055-61.
- 15. Ohashi Y, Dogru M, Tsubota K. Laboratory findings in tear fluid analysis. Clin Chim Acta. 2006;369(1):17-28. DOI: 10.1016/j.cca.2005.12.03510.1016/j.cca.2005.12.03516516878
- 16. Gorskova EN, Tarasova LN,Teplova SN, Sevostianov EN, Alekhina TV. State of local immunity in keratoconus. 3 Vestnilk Oftalmologii.1998;114(3):26-28.
- 17. Schnetler R, Gillan WDH, Korseen G. Immunological and antimicrobial molecules in human tears: a review and preliminary report. S Afr Optom.2012;71(3):123-32. DOI: 10.4102/aveh.v71i3.7910.4102/aveh.v71i3.79
- 18. Bao F, Geraghty B, Wang Q, Elsheikh A. Consideration of corneal biomechanics in the diagnosis and management of keratoconus:is it important? Eye Vis (Lond). 2016;3:18. DOI: 10.1186/s40662-016-0048-410.1186/s40662-016-0048-4493270427382596